Target intelligence / Profile preview

Phospholipid component of bacterial cell membrane

Molecular classification
Other
01

Overview

Phospholipid components of the bacterial cell membrane are fundamental amphipathic molecules forming the structural basis of the lipid bilayer that encloses the cytoplasm of bacteria[3][4][7]. These phospholipids define the cell’s boundary, enabling selective permeability, maintaining homeostasis, and providing a matrix for insertion of membrane proteins required for transport, signaling, and energy generation[2][1]. Bacterial membranes generally lack cholesterol but exhibit diverse phospholipid headgroups and acyl chain compositions, affecting membrane fluidity, charge, and interactions with proteins[3][4]. These components are not considered traditional pharmacological targets (such as specific receptors or enzymes) but constitute a crucial physicochemical barrier involved in antibiotic resistance and the mechanism of action for several membrane-acting antibacterial agents[5]. Because “phospholipid components of bacterial cell membrane” refers to a broad molecular class, rather than a defined, specific drug target, this entry does not match the usual standard for a singular, actionable therapeutic target—hence it is marked as “is_incorrect: true.”

Other names
Bacterial membrane phospholipidBacterial membrane lipid
02

Mechanism of action

Disruption of membrane integrity (e.g., polymyxins bind bacterial phospholipids and destabilize membranes) Depolarization of the cytoplasmic membrane (e.g., daptomycin interacts with phospholipids and causes loss of membrane potential)

03

Biological functions

Membrane structureSelective permeabilityRegulation of fluidityScaffold for membrane protein activityCellular compartmentalization
04

Disease associations

Infection (indirectly, via role in bacterial physiology and antibiotic resistance mechanisms)
05

Safety considerations

Drugs targeting membrane phospholipids risk toxicity due to similarity with host (human) membrane lipidsSelectivity is a challenge; potential for nephrotoxicity and neurotoxicity (as seen with polymyxins)
06

Interacting drugs

Polymyxins (e.g., colistin)

2 more in the full profile.

07

Biomarkers

Altered membrane lipid composition may serve in research or resistance profiling, but no standardized clinical biomarkers

Beyond the preview

Go deeper on Phospholipid component of bacterial cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipid component of bacterial cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call